FDANonrulemakingFDA-2026-D-1257
Who commented on this docket
Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing; Draft Guidance for Industry; Availability
12 organizations filed 12 public comments on Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 19d ago.
Organizations
12
Comments
12
RIN
—
Comment window
closed 19d ago
Commenters (12)
- Alliance for mRNA Medicinestrade assoc.1 filing · confidence 85%
- American Society of Gene & Cell Therapytrade assoc.1 filing · confidence 85%
- Cystic Fibrosis Foundationtrade assoc.1 filing · confidence 85%
- eXmoor Pharma Concepts Ltdunverified attribution1 filing · confidence 70%
- International Society for Stem Cell Researchtrade assoc.1 filing · confidence 85%
- Parenteral Drug Associationtrade assoc.1 filing · confidence 97%
- Pediatric Inclusion Alliancetrade assoc.1 filing · confidence 85%
- Personalized Medicine Coalitiontrade assoc.1 filing · confidence 85%
- Sana Biotechnology Inc.unverified attribution1 filing · confidence 70%
- The Alliance for Regenerative Medicinetrade assoc.1 filing · confidence 85%
- The Cure Coalitiontrade assoc.1 filing · confidence 85%
- University of Pennsylvania Health Systemunverified attribution1 filing · confidence 70%
Attribution is name-based and imperfect. regulations.gov data is public record.